A detailed history of Polar Asset Management Partners Inc. transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Polar Asset Management Partners Inc. holds 492,900 shares of OCUL stock, worth $4.89 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
492,900
Holding current value
$4.89 Million
% of portfolio
0.14%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.45 - $9.23 $3.18 Million - $4.55 Million
492,900 New
492,900 $4.29 Million
Q3 2023

Nov 14, 2023

BUY
$3.14 - $5.04 $828,215 - $1.33 Million
263,763 New
263,763 $828,000

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $764M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Polar Asset Management Partners Inc. Portfolio

Follow Polar Asset Management Partners Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Asset Management Partners Inc., based on Form 13F filings with the SEC.

News

Stay updated on Polar Asset Management Partners Inc. with notifications on news.